"Pentamidine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
Concept/Terms
Pentam- Pentam
- American Pharmaceutical Partners Brand 2 of Pentamidine Isethionate
NebuPent- NebuPent
- American Pharmaceutical Partners Brand 1 of Pentamidine Isethionate
Pentacarinat- Pentacarinat
- Sicor Brand of Pentamidine Isethionate
- JHC Brand of Pentamidine Isethionate
- Rhône-Poulenc Rorer Brand of Pentamidine Isethionate
- Aventis Brand of Pentamidine Isethionate
- GlaxoSmithKline Brand of Pentamidine Isethionate
Below are MeSH descriptors whose meaning is more general than "Pentamidine".
Below are MeSH descriptors whose meaning is more specific than "Pentamidine".
This graph shows the total number of publications written about "Pentamidine" by people in Harvard Catalyst Profiles by year, and whether "Pentamidine" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
1996 | 1 | 1 | 2 |
1998 | 0 | 3 | 3 |
1999 | 0 | 1 | 1 |
2000 | 1 | 1 | 2 |
2002 | 1 | 0 | 1 |
2003 | 0 | 1 | 1 |
2004 | 0 | 1 | 1 |
2005 | 0 | 1 | 1 |
2009 | 1 | 0 | 1 |
2011 | 0 | 1 | 1 |
2014 | 1 | 1 | 2 |
2016 | 1 | 0 | 1 |
2020 | 0 | 1 | 1 |
2022 | 0 | 1 | 1 |
2024 | 1 | 0 | 1 |
Below are the most recent publications written about "Pentamidine" by people in Profiles.
-
Development of a digital intervention for psychedelic preparation (DIPP). Sci Rep. 2024 02 19; 14(1):4072.
-
Preclinical Development of Pentamidine Analogs Identifies a Potent and Nontoxic Antibiotic Adjuvant. ACS Infect Dis. 2022 04 08; 8(4):768-777.
-
Higher risk of urinary tract infections in renal transplant recipients receiving pentamidine versus trimethoprim-sulfamethoxazole (TMP-SMX) for Pneumocystis pneumonia prophylaxis. Clin Transplant. 2020 11; 34(11):e14067.
-
In silico and in vitro comparative activity of green tea components against Leishmania infantum. J Glob Antimicrob Resist. 2019 09; 18:187-194.
-
Safety and Effectiveness of Intravenous Pentamidine for Prophylaxis of Pneumocystis jirovecii Pneumonia in Pediatric Hematology/Oncology Patients. J Pediatr Hematol Oncol. 2016 08; 38(6):e180-5.
-
Safe and Effective Prophylaxis with Bimonthly Intravenous Pentamidine in the Pediatric Hematopoietic Stem Cell Transplant Population. Pediatr Infect Dis J. 2016 Feb; 35(2):135-41.
-
IV pentamidine for primary PJP prophylaxis in adults undergoing allogeneic hematopoietic progenitor cell transplant. Bone Marrow Transplant. 2015 Sep; 50(9):1253-5.
-
Target-independent prediction of drug synergies using only drug lipophilicity. J Chem Inf Model. 2014 Aug 25; 54(8):2286-93.
-
Computational repositioning and preclinical validation of pentamidine for renal cell cancer. Mol Cancer Ther. 2014 Jul; 13(7):1929-1941.
-
Diamidine compounds for selective inhibition of protein arginine methyltransferase 1. J Med Chem. 2014 Mar 27; 57(6):2611-22.